We are live on ! Find out more
BBNX

Beta Bionics
BBNX

129 hedge funds and large institutions have $963M invested in Beta Bionics in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 21

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

46% more capital invested

Capital invested by funds: $659M → $963M (+$303M)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

11% more funds holding

Funds holding: 116 → 129 (+13)

7.77% more ownership

Funds ownership: 103.45% → 111.22% (+7.8%)

Holders
129
Holders Change
+13
Holders Change %
+11.21%
% of All Funds
1.69%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
29
Increased
58
Reduced
21
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$33.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$26.5M
3
Morgan Stanley
Morgan Stanley
New York
+$14.3M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.6M
5
State Street
State Street
Massachusetts
+$10.5M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$23.1M
2
DSCM
Divisadero Street Capital Management
Florida
-$13.8M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$13.5M
4
Holocene Advisors
Holocene Advisors
New York
-$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$98.5M +$438K +24,901 +0.5%
FCM
2
Farallon Capital Management
California
$85.7M +$1.93M +110,000 +3%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$77.5M – – –
SCM
4
Soleus Capital Management
Connecticut
$76.9M +$879K +50,000 +1%
Morgan Stanley
5
Morgan Stanley
New York
$74.7M +$14.3M +812,218 +28%
SCV
6
Sands Capital Ventures
Virginia
$70.9M – – –
RI
7
RTW Investments
New York
$65.6M – – –
BlackRock
8
BlackRock
New York
$55.3M +$33.8M +1,922,972 +224%
Vanguard Group
9
Vanguard Group
Pennsylvania
$44M +$26.5M +1,509,217 +213%
OFM
10
Omega Fund Management
Massachusetts
$38.2M -$1.2M -68,162 -3%
DM
11
Deerfield Management
New York
$23.2M – – –
DCM
12
Driehaus Capital Management
Illinois
$21M -$1.77M -100,762 -9%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$18.2M +$10.6M +604,623 +193%
State Street
14
State Street
Massachusetts
$16.4M +$10.5M +596,307 +259%
Millennium Management
15
Millennium Management
New York
$15.8M +$4.48M +254,766 +47%
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
$12.9M -$261K -14,828 -2%
VPC
17
Vestal Point Capital
New York
$11.9M +$879K +50,000 +9%
Marshall Wace
18
Marshall Wace
United Kingdom
$11.8M -$353K -20,063 -3%
Walleye Capital
19
Walleye Capital
New York
$11.7M +$6.55M +372,998 +171%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$9.69M +$2.98M +169,715 +53%
Goldman Sachs
21
Goldman Sachs
New York
$7.93M +$1.55M +88,252 +28%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$7.24M -$966K -54,950 -13%
Charles Schwab
23
Charles Schwab
California
$6.57M +$4.01M +228,467 +223%
Northern Trust
24
Northern Trust
Illinois
$5.92M +$3.56M +202,807 +213%
PVI
25
Pura Vida Investments
New York
$5.59M +$4.9M +278,750 +11,150%
1
2 3 4 5

BBNX Hedge Fund Activity: Q3 2025 in Review

129 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q3 2025, worth a combined $963M — up 46% from $659M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BBNX positions and 16 closed out — a net gain of 13 holders — while 58 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $33.8M. The largest seller was Perceptive Advisors, cutting an estimated $23.1M.

  • 129 institutional investors held Beta Bionics (BBNX) as of Q3 2025, up from 116 in Q2 2025.
  • Funds reported $963M of Beta Bionics stock for Q3 2025, up 46% quarter-over-quarter.
  • 29 funds opened new Beta Bionics positions in Q3 2025 and 16 closed out, a net change of +13 holders.
  • The largest Beta Bionics buyer in Q3 2025 was BlackRock, an estimated $33.8M added.
  • The largest Beta Bionics seller in Q3 2025 was Perceptive Advisors, an estimated $23.1M sold.

Based on aggregated 13F filings for Q3 2025.